C

Curis
D

CRIS

1.01500
USD
-0.08
(-6.88%)
مغلق
حجم التداول
2,613
الربح لكل سهم
-12
العائد الربحي
-
P/E
0
حجم السوق
2,461,454
أصول ذات صلة المقالات
المزيد

العنوان: Curis Inc.

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.